This file is a workload data table showing annual test volumes for various Chemiluminescent Immunoassay (CLIA) tests required by Brooke Army Medical Center. The table details testing requirements across a base year and four option years, with consistent volumes maintained throughout all periods. Key test volumes include: Treponema (12,600 tests/year), MeMed BV (9,400 tests/year), Calprotectin and various other tests like Measles, Mumps, Rubella IGG/IGM (2,800 tests/year each), and multiple other assays ranging from 400-800 tests annually including CMV, EBV, HSV, Toxo, Zika, and Lyme testing.
The table accompanies a Sources Sought Notice seeking vendors who can provide FDA-approved CLIA test kits compatible with the government's existing instrumentation for the period October 2025 through September 2030. These volumes represent the anticipated workload requirements that potential vendors would need to support at the Department of Pathology and Area Laboratory Services - Immunology Laboratory at Fort Sam Houston, Texas.
Department of the Army Medical Command